Maple Syrup Nutrition & Health: What the Evidence Says

Is maple syrup healthy? The short answer

If “healthy” means low in sugar or a food that should be eaten for its micronutrients, maple syrup does not fit that description. The USDA FoodData Central reference record used by MapleSyrup.eu lists about 260 kcal, 67.04 g of carbohydrate and 60.46 g of total sugars per 100 g. ^[1]

Maple syrup also contains measurable quantities of minerals, including manganese, calcium, potassium, magnesium and zinc, and researchers have identified a range of phenolic compounds and other minor constituents. ^[1][2]

Those two facts can be true at the same time. Maple syrup can contain chemically interesting compounds while still being, in ordinary dietary terms, a sugar-rich sweetener.

What is in maple syrup?

For a transparent reference point, MapleSyrup.eu uses USDA FoodData Central’s SR Legacy entry “Syrups, maple” (FDC ID 169661). The record gives the following values per 100 g: 260 kcal, 67.04 g carbohydrate, 60.46 g total sugars, almost no fat or protein, and measurable amounts of several minerals. ^[1]

A 20 g portion calculated from those values would contain about 52 kcal and 12.1 g of total sugars. It would also provide about 0.58 mg of manganese, 20 mg of calcium and 42 mg of potassium. The point of showing a smaller portion is not to prescribe a serving size; it is to keep micronutrient numbers in realistic dietary context.

Composition varies naturally and between products, so a reference database should not be treated as a laboratory certificate for every bottle. For a packaged product, its own nutrition declaration remains the most relevant information for that specific product.

Sugar is still the nutritional starting point

The clearest way to understand maple syrup nutritionally is to begin with what dominates the food, not with its most marketable trace constituents.

USDA reference data show that carbohydrate accounts for virtually all of maple syrup’s macronutrient content, with sugars forming most of that carbohydrate. ^[1] That matters because claims such as “natural sweetener” or “less refined” can create a health halo that is much broader than the composition warrants.

This does not mean that maple syrup is chemically identical to table sugar. It is not. But being compositionally different from sucrose does not automatically establish a meaningful health advantage in normal use.

What about minerals?

Maple syrup contains measurable minerals. Manganese is particularly notable in the USDA reference profile, while calcium, potassium, magnesium and zinc are also present. ^[1]

The important consumer question is how those figures relate to the amount of syrup people actually eat. Nutrient values quoted per 100 g can make a sweetener look more impressive than the same values viewed in a much smaller portion. That is why MapleSyrup.eu shows both a 100 g reference and an illustrative 20 g calculation.

It would be misleading to jump from “contains minerals” to “eat maple syrup for minerals”. Nutrient-content claims in the EU are regulated and must meet defined conditions. ^[4][5] Even where a product meets a compositional threshold, the broader dietary context still matters.

Polyphenols and “antioxidants”: chemistry is not a health outcome

Peer-reviewed reviews of maple syrup chemistry describe numerous phenolic compounds and other minor constituents. ^[2] Researchers have also studied antioxidant-related and other biological activities in laboratory and preclinical settings.

This is scientifically interesting. It is not the same as showing that ordinary maple syrup consumption prevents disease or improves health in people.

That distinction is essential because online articles often collapse three separate statements into one:

1. a compound has been identified in maple syrup;
2. that compound or an extract shows biological activity in a laboratory model;
3. eating maple syrup therefore produces a meaningful health benefit in humans.

The first statement can be well supported while the third remains unproven. MapleSyrup.eu will therefore describe phenolics as components that are present and under study, not as a licence for disease-prevention or “antioxidant health” claims.

What did the 2024 human trial find?

Human intervention research is more relevant to health questions than a test tube, but the available evidence still needs careful boundaries.

A 2024 randomized, double-blind, controlled crossover trial enrolled 42 overweight adults with mild cardiometabolic alterations. Participants replaced refined sugars representing 5% of total caloric intake with either maple syrup or an artificially flavoured sucrose syrup for eight weeks, then crossed over after a washout period. ^[3]

Compared with the sucrose-syrup condition, the maple-syrup condition produced statistically significant differences in several reported outcomes, including glucose response during an oral glucose tolerance test, android fat mass and systolic blood pressure. The investigators did not observe changes in the blood lipid profile between the interventions. ^[3]

That is legitimate emerging human evidence. It is also a long way from a universal conclusion that “maple syrup is healthier than sugar”. The study was small, short, involved a selected group rather than the general population, and tested a specific substitution design rather than unrestricted maple-syrup consumption. It was funded by the Québec maple producer organisation PPAQ and the Québec agriculture ministry MAPAQ; the paper states that the sponsors had no role in study design, data collection or analysis, interpretation, writing or the decision to publish. ^[3]

The responsible summary is therefore: one controlled trial found potentially interesting differences under specific conditions, and independent replication and longer-term evidence are still needed before broad health conclusions would be justified.

What about the glycaemic index?

Numbers around the mid-50s are frequently repeated online for maple syrup’s glycaemic index. The MapleSyrup.eu foundation review deliberately did not promote a precise value because it could not trace that commonly repeated figure to a sufficiently transparent original standardised GI test suitable for a strong standalone consumer claim. ^[7]

For V1, that uncertainty is more important than the appeal of publishing a neat number. We therefore do not describe maple syrup as “low GI” and do not use a specific 54 or 55 figure as a health argument.

This is also a useful reminder that one numerical metric cannot turn a concentrated sugar-rich sweetener into a food that is automatically suitable for everyone, including people with diabetes.

Is maple syrup healthier than table sugar?

There is no good evidence basis for a simple universal verdict.

Maple syrup differs from refined sucrose because it contains water, minerals, organic acids and a variety of minor compounds. ^[1][2] The 2024 trial suggests that replacing a defined amount of refined sugar with maple syrup may produce different short-term responses in a selected population. ^[3]

But “healthier” is a much broader claim. It could refer to blood glucose, body weight, cardiovascular outcomes, dental health, nutrient intake, long-term disease risk or many other endpoints. One small short-term trial cannot answer all of those questions.

For everyday consumers, the most defensible conclusion is simpler: maple syrup can be chosen for its flavour, origin and culinary qualities, but it should still be understood nutritionally as a sugar-rich sweetener rather than as a health product.

What EU health-claim rules mean for maple syrup

European food law draws an important line between descriptive information and claims of nutritional or health benefit.

Regulation (EC) No 1924/2006 governs nutrition and health claims on foods. The European Commission lists specific permitted nutrition claims and their conditions, while EFSA evaluates the scientific substantiation of health claims that enter the authorisation process. ^[4][5][6]

This matters because a scientific paper and an authorised consumer claim are not the same thing. A study can be worth reporting editorially while still providing no legal basis for marketing a bottle as “heart healthy”, “anti-inflammatory” or “clinically proven healthier than sugar”.

MapleSyrup.eu therefore keeps two questions separate:

• What does research say?
• What health or nutrition claim may legally be made in EU commercial communication?

The answer to the second question depends on the specific wording, authorised claim framework and product composition - not merely on whether a favourable study exists.

A practical evidence-based view

Maple syrup does not need a health halo to be an interesting food. It has a distinctive flavour, a documented production tradition and a chemical composition that differs from refined sucrose. It contains measurable minerals and phenolic compounds, and early human research has produced results worth following.

But the strongest current evidence still supports a restrained consumer message: maple syrup is primarily a sugar-rich sweetener. Enjoying it instead of another sweetener can be a culinary choice. Turning that choice into a claim of disease prevention, metabolic protection or general health superiority would go beyond what the evidence currently establishes.

That is the standard MapleSyrup.eu will apply as the science develops: distinguish what is present, what has been tested, what has been demonstrated in people, and what remains unproven.